|
RPP40 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.373610E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.135200E-01 |
| Normal-vs-Stage2 |
1.008950E-01 |
| Normal-vs-Stage3 |
5.708000E-02 |
| Normal-vs-Stage4 |
6.401900E-03 |
| Stage1-vs-Stage2 |
3.268200E-02 |
| Stage1-vs-Stage3 |
7.309800E-02 |
| Stage1-vs-Stage4 |
9.222300E-03 |
| Stage2-vs-Stage3 |
2.681600E-03 |
| Stage2-vs-Stage4 |
4.218100E-04 |
| Stage3-vs-Stage4 |
1.025350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.193980E-01 |
| Normal-vs-AfricanAmerican |
4.101800E-01 |
| Normal-vs-Asian |
4.550000E-01 |
| Caucasian-vs-AfricanAmerican |
9.537200E-01 |
| Caucasian-vs-Asian |
9.835600E-02 |
| AfricanAmerican-vs-Asian |
1.707970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.588800E-01 |
| Normal-vs-Female |
1.811530E-02 |
| Male-vs-Female |
6.128500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.204400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.588400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.102980E-01 |
| Normal-vs-Age(81-100Yrs) |
7.473800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.299200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.602800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.983000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.671000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.418600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.814200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.963000E-01 |
| Normal-vs-Grade 2 |
8.323000E-01 |
| Normal-vs-Grade 3 |
1.686650E-01 |
| Normal-vs-Grade 4 |
8.340800E-03 |
| Grade 1-vs-Grade 2 |
5.600800E-01 |
| Grade 1-vs-Grade 3 |
3.462800E-01 |
| Grade 1-vs-Grade 4 |
2.494000E-02 |
| Grade 2-vs-Grade 3 |
1.590960E-01 |
| Grade 2-vs-Grade 4 |
8.541200E-03 |
| Grade 3-vs-Grade 4 |
4.312200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.623400E-01 |
| Normal-vs-ccB subtype |
1.440200E-01 |
| ccA subtype-vs-ccB subtype |
2.524000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.346000E-01 |
| Normal-vs-N1 |
1.431400E-01 |
| N0-vs-N1 |
2.648600E-01 |
|
|
